Tissue | Drug | Disease | Value |
---|---|---|---|
Pancreas | Acetylsalicylic acid (DB00945) | Diabetes Mellitus, Noninsulin-Dependent (125853) | 0.20 |
Pancreas | Acetylsalicylic acid (DB00945) | Cystic fibrosis by Pseudomonas aeruginosa (219700) | 0.32 |
Pancreas | Acetaminophen (DB00316) | Diabetes Mellitus, Noninsulin-Dependent (125853) | 0.13 |
Pancreas | Acetaminophen (DB00316) | Cystic fibrosis by Pseudomonas aeruginosa (219700) | 0.26 |
Skeletal Muscle | Acetaminophen (DB00316) | Myasthenic syndrome (601462) | 0.22 |
Skin | Lorazepam (DB00186) | Immunodysregulation, Polyendo-crinopathy, And X-Linked Enteropathy (304790) | 0.17 |
Testis | Lorazepam (DB00186) | Persistent Mullerian duct syndrome, type II (261550) | 0.09 |
Testis | Alprazolam (DB00404) | Persistent Mullerian duct syndrome, type II (261550) | 0.10 |
Testis | Acetaminophen (DB00316) | Persistent Mullerian duct syndrome, type II (261550) | 0.24 |
Heart | Acetylsalicylic acid (DB00945) | Thrombosis, Susceptibility to thrombin defect; thph1 (188050) | 0.20 |
Heart | Acetaminophen (DB00316) | Thrombosis, Susceptibility to thrombin defect; thph1 (188050) | 0.33 |
Heart | Acetaminophen (DB00316) | Afibrinogenemia, congenital (202400) | 0.25 |
Heart | Acetylsalicylic acid (DB00945) | Afibrinogenemia, congenital (202400) | 0.24 |